Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026

ROCKVILLE, Md. and SUZHOU, China, March 17, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biop...

Early report Major update Updated Mar 18, 2026, 12:00 AM UTC

Track this event Edit in app More event pages

What changed

GlobeNewswire Public Companies: Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR)….

First seen Mar 18, 2026, 12:00 AM UTC Latest source Mar 18, 2026, 12:00 AM UTC

Update 1 1h ago

Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026

GlobeNewswire Public Companies •published Mar 18, 2026, 12:00 AM UTC •fetched Mar 18, 2026, 12:02 AM UTC

Event stats

Reports 1

Sources 1

Confidence low

Score 41

Entity focus

AscentagePharmaPresentDataFrom

Source spread

GlobeNewswire Public Companies

Turn this into an alert

Draft the watch from the event wording, then let PushMe handle follow-up changes.

Notify me about major new developments on Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026, especially invol…

Create alert from this event